The case for sunscreens: A review of their use in preventing actinic damage and neoplasia

Archives of Dermatology

Volumn 133, Issue 9, 1997, Pages 1146-1154

  Naylor, Mark F ^a   Farmer, Kevin C ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID DERIVATIVE; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; SUNSCREEN; VITAMIN D;

ANIMAL MODEL; CANCER PREVENTION; CANCER RISK; CLINICAL ARTICLE; DNA DAMAGE; GENOTOXICITY; HUMAN; MELANOMA; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION PROTECTION; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY;

EID: 0030961199     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.9.1146     Document Type: Review

References (50)

1. Tornaletti S, Rozek D, Pfeifer GP. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene. 1993;8:2051-2057.
2. Pence BC, Naylor MF. Effects of single-dose ultraviolet radiation on skin superoxide dismutase, catalase, and xanthine oxidase in hairless mice. J Invest Dermatol. 1990;95:213-216.
3. Reid TM, Loeb LA. Tandem double CC→TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci U S A. 1993;90:3904-3907.
4. Stewart MS, Cameron GS, Pence BC. Antioxidant nutrients protect against UVB-induced oxidative damage to DNA of mouse keratinocytes in culture. J Invest Dermatol. 1996;106:1086-1089.
5. Andersen PH, Abrams K, Bjerring P, Maibach H. A time-correlation study of ultraviolet B - induced erythema measured by reflectance spectroscopy and laser Doppler flowmetry. Photodermatol Photoimmunol Photomed. 1991;8:123-128.
6. Ramani ML, Bennett RG. High prevalence of skin cancer in World War II servicemen stationed in the Pacific theater. J Am Acad Dermatol. 1993;28:733-737.
7. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma: a case-control study in Western Australia. Int Cancer. 1995;60:489-494.
8. Lowe NJ, Breeding J. Evaluation of sunscreen protection by measurement of epidermal DMA synthesis. J Invest Dermatol. 1980;74:181-182.
9. Freeman SE, Ley RD, Ley KD. Sunscreen protection against UV-induced pyrimidine dimers in DNA of human skin in situ. Photodermatology. 1988;5:243-247.
10. Wolf P, Yarosh DB, Kripke ML. Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol. 1993;101:523-527.
11. van Praag MC, Roza L, Boom BW, et al. Determination of the photoprotective efficacy of a topical sunscreen against UVB-induced DNA damage in human epidermis. J Photochem Photobiol B. 1993;19:129-134.
12. Gallagher CH, Greenoak GE, Reeve VE, et al. Ultraviolet carcinogenesis in the hairless mouse skin: influence of the sunscreen 2-ethylhexyl-p-methoxycinnamate. Aust J Exp Biol Med Sci. 1984;62:577-588.
13. van Weelden H, van der Putte SC, Toonstra J, van der Leun JC. UVA-induced tumours in pigmented hairless mice and the carcinogenic risks of tanning with UVA. Arch Dermatol Res. 1990;282:289-294.
14. Gallagher CH, Canfield PJ, Greenoak GE, Reeve VE. Characterization and histogenesis of tumors in the hairless mouse produced by low-dosage incremental ultraviolet radiation. J Invest Dermatol. 1984;83:169-174.
15. Kripke ML, Fisher MS. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst. 1976;57:211-215.
16. Nishigori C, Yarosh DB, Donawho C, Kripke ML. The immune system in ultraviolet carcinogenesis. J Invest Dermatol Symp Proc. 1996;1:143-146.
17. Miyagi T, Bhutto A, Nonaka S. The effects of sunscreens on UVB erythema and Langerhans cell depression. J Dermatol. 1994;21:645-651.
18. Whitmore SE, Morison WL. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermatol. 1995; 131:1128-1133.
19. Roberts LK, Beasley DG. Commercial sunscreen lotions prevent ultraviolet-radiation-induced immune suppression of contact hypersensitivity. J Invest Dermatol. 1995;105:339-344.
20. Bestak R, Barnetson RS, Nearn MR, Halliday GM. Sunscreen protection of contact hypersensitivity responses from chronic solar-simulated ultraviolet irradiation correlates with the absorption spectrum of the sunscreen. J Invest Dermatol. 1995;105:345-351.
21. Reeve VE, Bosnic M, Boehm-Wilcox C, Ley RD. Differential protection by two sunscreens from UV radiation-induced immunosuppression. J Invest Dermatol. 1991;97:624-628.
22. Kligman LH, Akin FJ, Kligman AM. Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol. 1980;3:30-35.
23. Snyder DS, May M. Ability of PABA to protect mammalian skin from ultraviolet light-induced skin tumors and actinic damage. J Invest Dermatol. 1975;65: 543-546.
24. Boyd AS, Naylor M, Cameron GS, et al. The effects of chronic sunscreen use on the histologic changes of dermatoheliosis. J Am Acad Dermatol. 1995;33:941-946.
25. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor (SPF) sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170-175.
26. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.
27. Matsuoka LY, Wortsman J. Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. Arch Dermatol. 1988; 124:1802-1804.
28. Harju E, Sotaniemi E, Puranen J, Lahti R. High incidence of low serum vitamin D concentration in patients with hip fracture. Arch Orthop Trauma Surg. 1985; 103:408-416.
29. Thompson SP, Wilton TJ, Hosking DJ, White DA, Pawley E. Is vitamin D necessary for skeletal integrity in the elderly? J Bone Joint Surg Br. 1990;72.1053-1056.
30. Marks R, Foley PA, Jolley D, et al. The effect of regular sunscreen use on vitamin D levels in an Australian population: results of a randomized controlled trial. Arch Dermatol. 1995;131:415-421.
31. Knowland J, McKenzie EA, McHugh PJ, Cridland NA. Sunlight-induced mutagenicity of a common sunscreen ingredient. FEBS Lett. 1993;324:309-313.
32. Urbach F. Sunscreen not mutagenic. Med J Aust. 1980;2:284.
33. Wolf P, Donawho CK, Kripke ML. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J Natl Cancer Inst. 1994; 86:99-105.
34. Cannon-Albright LA, Meyer LJ, Goldgar DE, et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res. 1994; 54:6041-6044.
35. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17:459-468.
36. Krüger S, Garbe C, Büttner P, et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. J Am Acad Dermatol. 1992;26:920-926.
37. Slade J, Marghoob AA, Salopek TG, et al. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol. 1995;32:479-494.
38. Abadir MC, Marghoob AA, Slade J, et al. Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol. 1995;33:31-36.
39. Garland FC, White MR, Garland CF, Shaw E, Gorham ED. Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health. 1990;45:261-267.
40. Weinstock MA, Stampfer MJ, Lew RA, Willett WC, Sober AJ. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol. 1992;98:809-811.
41. Anders A, Altheide HJ, Knalmann M, Tronnier H. Action spectrum for erythema in humans investigated with dye lasers. Photochem Photobiol. 1995;61:200-205.
42. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid. Proc Natl Acad Sci U S A. 1989; 86:8922-8926.
43. Autier P, Dore JF, Schifflers E, et al. Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France, Int J Cancer. 1995;61: 749-755.
44. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia: analysis of trends between 1931 and 1994. BMJ. 1996;312:1121-1125.
45. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-776.
46. Kaidbey KH. The photoprotective potential of the new superpotent sunscreens. J Am Acad Dermatol. 1990;22:449-452.
47. Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma, Int J Cancer. 1995;60:482-488.
48. Naylor MF. Erythema, skin cancer risk and sunscreens. Arch Dermatol. 1997; 133:373-375.
49. Wulf HC, Poulsen T, Brodthagen H, Hou-Jensen K. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol. 1982;7:194-202.
50. Naylor MF. High sun protection factor sunscreens in the suppression of actinic neoplasia. Care & Cure: Dear Colleague, Dermatology. 1996;4:7-8.